Literature DB >> 27599006

HIV and Hormonal Contraception: Bench and Bedside.

Nirk E Quispe Calla1, Rodolfo D Vicetti Miguel, Wayne Trout, Thomas L Cherpes.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 27599006      PMCID： PMC6781862          DOI： 10.1097/QAI.0000000000001174

Source DB:  PubMed          Journal:  J Acquir Immune Defic Syndr        ISSN： 1525-4135            Impact factor:   3.731


× No keyword cloud information.
  6 in total

1.  Committee opinion no. 539: adolescents and long-acting reversible contraception: implants and intrauterine devices.

Authors: 
Journal:  Obstet Gynecol       Date:  2012-10       Impact factor: 7.661

2.  Estrogen protects against vaginal transmission of simian immunodeficiency virus.

Authors:  S M Smith; G B Baskin; P A Marx
Journal:  J Infect Dis       Date:  2000-08-08       Impact factor: 5.226

Review 3.  Use of hormonal contraceptives and HIV acquisition in women: a systematic review of the epidemiological evidence.

Authors:  Chelsea B Polis; Kathryn M Curtis
Journal:  Lancet Infect Dis       Date:  2013-07-19       Impact factor: 25.071

4.  Topical estrogen protects against SIV vaginal transmission without evidence of systemic effect.

Authors:  Stephen M Smith; Megan Mefford; Donald Sodora; Zachary Klase; Mahender Singh; Nancy Alexander; David Hess; Preston A Marx
Journal:  AIDS       Date:  2004-08-20       Impact factor: 4.177

Review 5.  Critical Review: Mechanisms of HIV Transmission in Depo-Provera Users: The Likely Role of Hypoestrogenism.

Authors:  Martha Hickey; Jennifer L Marino; Gilda Tachedjian
Journal:  J Acquir Immune Defic Syndr       Date:  2016-01-01       Impact factor: 3.731

6.  Medroxyprogesterone acetate and levonorgestrel increase genital mucosal permeability and enhance susceptibility to genital herpes simplex virus type 2 infection.

Authors:  N E Quispe Calla; R D Vicetti Miguel; P N Boyaka; L Hall-Stoodley; B Kaur; W Trout; S D Pavelko; T L Cherpes
Journal:  Mucosal Immunol       Date:  2016-03-23       Impact factor: 7.313
  6 in total
  6 in total

1.  Levonorgestrel and Female Genital Tract Immunity: Time for a Closer Look.

Authors:  Rodolfo D Vicetti Miguel; Nirk E Quispe Calla; Thomas L Cherpes
Journal:  J Infect Dis       Date:  2018-09-22       Impact factor: 5.226

2.  Depot-medroxyprogesterone acetate reduces genital cell-cell adhesion molecule expression and increases genital herpes simplex virus type 2 infection susceptibility in a dose-dependent fashion.

Authors:  Nirk E Quispe Calla; Rodolfo D Vicetti Miguel; Kristen M Aceves; Angelo Torres; Thomas L Cherpes
Journal:  Contraception       Date:  2019-07-11       Impact factor: 3.375

3.  Dual contraceptive use and associated factors among women aged 15-49 years on antiretroviral therapy in Kayonza District, Rwanda: a cross-sectional study.

Authors:  Jean Nepomuscene Renzaho; Erigene Rutayisire
Journal:  Pan Afr Med J       Date:  2022-05-17

4.  Utilisation of immediate postpartum family planning among postpartum women at public hospitals of North Shoa Zone, Ethiopia: a cross-sectional study.

Authors:  Mulualem Silesh; Tesfanesh Lemma; Samuel Abdu; Belete Fenta; Mesfin Tadese; Birhan Tsegaw Taye
Journal:  BMJ Open       Date:  2022-02-24       Impact factor: 2.692

5.  Exogenous oestrogen inhibits genital transmission of cell-associated HIV-1 in DMPA-treated humanized mice.

Authors:  Nirk E Quispe Calla; Rodolfo D Vicetti Miguel; Melissa E Glick; Jesse J Kwiek; Janelle M Gabriel; Thomas L Cherpes
Journal:  J Int AIDS Soc       Date:  2018-01       Impact factor: 5.396

6.  Exogenous sex steroids regulate genital epithelial barrier function in female rhesus macaques.

Authors:  Nirk E Quispe Calla; Rodolfo D Vicetti Miguel; Linda Fritts; Christopher J Miller; Kristen M Aceves; Thomas L Cherpes
Journal:  Biol Reprod       Date:  2020-08-04       Impact factor: 4.285
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.